Van beleggers
voor beleggers
Uitgebreid zoeken

Beurscodes, betekenis en hulp bij zoeken

Europa

AEX
Euronext Amsterdam
BRU
Euronext Brussels
PSE
Euronext Paris
LIS
Euronext Lissabon
CHX
CBOE Europe, grote(re) EU aandelen
NAV
Investment Funds (NAV)

Noord-Amerika

NYS
New York Stock Exchange
OTC
CBOE BZX Exchange (US)
TSE
Toronto Stock Exchange

Kunt u een instrument niet vinden?

Zoek dan via de zogenaamde ISIN code. Elk instrument, aandeel etc. heeft een unieke code.

Kies vervolgens - wanneer er meerdere resultaten zijn - de notering op de beurs van uw keuze.

Waar vind ik die ISIN code?

Google de naam van het instrument, aandeel etc. met de toevoeging 'ISIN'.

Als zoeken op ISIN code geen resultaten oplevert hebben wij het instrument of aandeel niet in onze koersendatabase.

desktop iconMarkt Monitor
  • Word abonnee
  • Inloggen

    Inloggen

    • Geen account? Registreren

    Wachtwoord vergeten?
Home  /  Forum  /  Pharming  /  Pharming het aandeel van 2017 deel 2

Ontvang nu dagelijks onze kooptips!

word abonnee

Aandeel Pharming Group AEX:PHARM.NL, NL0010391025

  • 0,868 18 apr 2024 17:35
  • 0,000 (0,00%) Dagrange 0,861 - 0,957
  • 37.599.271 Gem. (3M) 6,9M

Pharming het aandeel van 2017 deel 2

21.830 Posts
Pagina: «« 1 ... 34 35 36 37 38 ... 1092 »» | Laatste | Omlaag ↓
  5. rightdevil1977 1 november 2017 21:21
    quote:

    Prof. Dollar schreef op 1 november 2017 21:18:

    [...]
    thestocktalker.com/stock-rundown-phar...
    dank je wel stomme edit reactie. Zodra je edit reactie doet begin je altijd weer met de reactie die je als eerste getypt hebt, heb ook volgende link nog gevonden:

    nlrnews.com/turning-our-focus-to-phar...
  7. Petex 1 november 2017 21:23
    Ik ga eerlijk toegeven, dat ik vandaag wederom uitgestapt ben en een leuke winst heb veilig gesteld......
    Ik weet het....ben tegen mijn beleid in gegaan qua Pharming aandelen en spreek mezelf nu tegen....sorry daarvoor, maar bewuste keuze vandaag.
    Zo te lezen ben ik overigens niet de enige die winst heeft genomen.....
    Ik ben van oorsprong een LT belegger en absoluut geen KT trader, maar op een of andere manier durf ik niet nog verder met Pharming op deze koers........
    Heb een switch gemaakt naar Ahold vandaag naast mijn andere aandelen in andere bedrijven.
    Mocht Pharming onverhoopt weer gaan duiken (verwacht ik niet overigens....) ga ik er zeker weer over denken opnieuw in te stappen.

    Welgemeend succes allemaal en fijne avond nog!
  8. [verwijderd] 1 november 2017 21:26
    Turning Our Focus to Pharming Group NV (:PHGUF)

    November 1, 2017 Nelson Research Staff


    Pharming Group NV (:PHGUF) has been getting interest from investors after the stock price touched $1.1 at the conclusion of the most recent trade. The stock is traded on OTC in the Medical sector and Medical – Biomedical and Genetics industry.

    The mathematical calculation that represents the degree of change over time is known as “percentage change”. In finance, it serves many purposes, and is often used to represent the price change of a commodity.

    Pharming Group NV (:PHGUF)’s Price Change % over the last week is 25%. It’s % Price Change over the previous month is 24.29% and previous three months is 111.54%. Finally, looking back over the past year-to-date, Pharming Group NV (:PHGUF)’s Price Change % is 340%.

    Percentage change can be applied to any quantity that is measured over time any given time period. Say you are tracking the price of a stock. If the price increased, the formula [(New Price – Old Price)/Old Price] is applied and then take that number and multiply it by 100. If the price of a stock decreased, the formula [(Old Price – New Price)/Old Price] is applied then multiplied by 100. The formula can be used to track the prices of both individual commodities and large market listings, and also used to compare the values of different currencies. Balance sheets with comparative financial statements often will include prices of specific stocks at different time periods alongside the percentage change over the same periods of time.

    Average Volume is the amount of securities traded in a day on average over a specific time period. Trading activity relates to the liquidity of a security. When average volume is high, the stock has high liquidity and can be therefore easily traded, while conversely, when the trading volume is low, the commodity will be less expensive as traders are not as willing to purchase it. Average volume has an effect on the price of the security. Pharming Group NV (:PHGUF) has seen 69323.15 shares trade hands on an average basis.

    Pharming Group NV (:PHGUF)’s 52-Week High-Low Range Price % is 100. Countless factors affect a security’s price and, therefore, its range. Macroeconomic factors such as interest rates and the economic cycle significantly impact the price of securities over lengthy periods of time. A big recession, for example, can dramatically widen the price range equities as they plummet in price.

    Considering that price volatility is equivalent to risk, a commodity’s trading range is a great indicator of risk. Conservative investors will gravitate towards securities with smaller price fluctuations as compared to securities with larger price swings, preferring to invest in relatively stable sectors such as health care, utilities, and telecommunications and avoiding high-beta sectors like commodities, technology, and financials.

    A 52-week high/low is the highest and lowest share price that a stock has traded at during the previous year. Investors and traders consider the 52-week high or low as a crucial factor in determining a given stock’s current value while also predicting future price movements. When a commodity trades within its 52-week price range (the range that exists between the 52-week low and the 52-week high), investors usually show more interest as the price nears either the high or the low.

    One of the more popular strategies used by traders is to buy when the price eclipses its 52-week high or to sell when the price drops below its 52-week low. The rationale involved with this strategy says that if the price breaks out either above or below the 52-week range, there is momentum enough to continue the price fluctuation in a positive direction. Pharming Group NV (:PHGUF)’s high over the last year was $1.1 while its low was $0.22.

    Beta measures the volatility of a security in comparison to the market as a whole. The tendency of a security’s returns is to respond to swings in the market. For example, a beta of 1 means that the security’s price will move in lockstep with the market. A beta of less than 1 indicates that the security will be less volatile relative to the market. A beta of greater than 1 tells us that the security’s price will be more volatile than the market. Beta is an expression of the tradeoff between maximizing return and minimizing risk. Pharming Group NV (:PHGUF)’s Beta number is 1.85.

    Outstanding Shares refers to all stocks currently held by all shareholders, including blocks held by institutional and insider investors, of a given company. Outstanding shares are shown on a company’s balance sheet as “Capital Stock.” The number of shares outstanding is used to calculate key metrics such as a company’s earnings per share (EPS), cash flow per share (CFPS) and its market cap. The number of outstanding shares is not static, as it can fluctuate greatly over time. Pharming Group NV (:PHGUF)’s number of shares outstanding is 520.07m.

    Knowing as much as you can about the penny stock world is extremely important if you want to make money in trading.

    It is highly recommended that you wade in toes first with a small amount of money to lessen the risk should you incur a loss.

    The first step in investing in penny stocks is to get money, as with any stock market transaction. One of the more significant traits of penny stocks is that they are volatile and move quickly. Penny stocks are stocks of small cap companies that can be vulnerable to stock market sentiments and industry changes.

    Though penny stocks are considered to be a risky investment, generally, a trader can make a large amount of money with them in a short period of time, as opposed to bigger, so-called “blue chip” stocks and mutual funds, which require a long-term approach.

    Needless to say, penny stock investing is not for the weak of heart, and only “play money” or non-essential disposable income should be invested in this kind of market.

    In no way are penny stocks considered to be conservative investments and people who play them must be willing and able to take risks with their investment money. Penny stock investors must be prepared to lose their entire investment sometimes. Penny stocks move fast in both directions, including massive upticks or downticks in a matter of hours or less.

    Potential penny stock investors must educate themselves first to gain knowledge of the market. They must also conduct intense research into any company they might want to put their money into. An education can start by subscribing to a penny stock newsletter which provides informative penny stock suggestions.
  15. [verwijderd] 1 november 2017 21:50
    quote:

    Deneus schreef op 1 november 2017 21:46:

    Als er bericht komt vanuit pharming of fda ben je echt de sjaak als je geen aandelen in bezit hebt.
    Denk aan profylactisch toedienen, shire weer in de problemen, overname, etc.
    Analisten met koersdoel 1.55 zou persoonlijk niet uitstappen je weet maar nooit.
    En dan heb je nog wat moet komen met de Q4 cijfers.
    Als we nu technisch gezien al €6.5m winst hebben, gooi nog eens €70m omzet voor Q4 er tegenaan... xD
  19. rightdevil1977 1 november 2017 21:53
    quote:

    freebs schreef op 1 november 2017 21:50:

    [...]
    Per vandaag zou dit inderdaad kunnen lukken,,, maar ik zou eerst voor hypotheekvrij gaan,,, maar van mijn ega komen er nog een paar "wensen" bij.
    als ik hypotheekvrij wil dan mag het aandeel eerst wel op 20 euro staat, haha
21.830 Posts
Pagina: «« 1 ... 34 35 36 37 38 ... 1092 »» | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.

Direct naar Forum

Premium

Logische herfinanciering Pharming

Het laatste advies leest u als abonnee van IEX Premium

Inloggen Word Abonnee

Pharming Nieuws

  1. 18 apr Pharming rondt plaatsing obligaties af 5
  2. 18 apr Pharming vervangt converteerbare lening 6
  3. 08 apr Pharming rondt rekrutering voor klinische studie leniolisib met kinderen af
  4. 14 mrt CEO: Pharming haalt omzet uit steeds meer landen 2
  5. 14 mrt Lichte plus voor AEX voorzien; zullen Pharming en Basic-Fit de boel opschudden?
  6. 14 mrt Pharming rekent ook voor 2024 op dubbelcijferige omzetgroei 2
  7. 13 mrt Slotcall: Twijfel slaat toe bij chippers, AEX sluit iets lager na wispelturige sessie
  8. 11 mrt Beursblik: hogere jaaromzet Pharming verwacht
  9. 11 mrt AEX gaat opnieuw rode opening tegemoet, Japan ontloopt recessie maar Nikkei duikelt 1
  10. 14 feb Video-update: AEX index, Brunel en Pharming

Lees verder op het IEX netwerk Let op: Artikelen linken naar andere sites

Gesponsorde links

Meld u aan voor de dagelijkse Beursupdate

Dagelijks een update van het laatste beursnieuws en beleggingskansen in uw mailbox!